Some highlights from the report after briefly skimming through it.
- CPW1 indicated that they used ChatGPT regularly for around one month prior to the PA Report incident. CPW1 claimed that they used ChatGPT to save time and to present work more professionally.
- DFFH also interviewed staff in CPW1’s team. It was indicated that CPW1’s use of ChatGPT had been well known within the team for a period of around 3 – 4 months and possibly longer, and that they had demonstrated to other team members how it could be used. There were no admissions that other members of the team had used ChatGPT.
- Ultimately, DFFH found there were 100 cases with indicators that ChatGPT may have been used to draft child protection documents. The types of documents involved court reports, case notes, case plans and risk assessments...
- ... DFFH identified that nearly 900 employees had accessed the ChatGPT website within this period. This represents almost 13 per cent of DFFH’s workforce of around 7,000 employees.
Copyright State of Victoria (Office of the Victorian Information Commissioner) CC BY 4.0
I find this information very distributing.
Not medical advice, just sharing research :)
Clinical experience with the α2A-adrenoceptor agonist, guanfacine, and N-acetylcysteine for the treatment of cognitive deficits in “Long-COVID19”
These are more relevant to either possibly reducing infection or possibly helping with an acute infection. I think that things that may help limit (re)infection are helpful to mention here.
Azelastine:
Antiviral Potential of Azelastine against Major Respiratory Viruses
Early intervention with azelastine nasal spray may reduce viral load in SARS-CoV-2 infected patients
Carrageenan:
Carrageenan nasal spray may double the rate of recovery from coronavirus and influenza virus infections: Re‐analysis of randomized trial data
Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease
Cetylpyridinium Chloride:
Efficacy of Cetylpyridinium Chloride mouthwash against SARS-CoV-2: A systematic review of randomized controlled trials
Melatonin / melatonergic drugs:
these are a bit more dubious
animal testing
Therapeutic potential of melatonin and melatonergic drugs on K18-hACE2 mice infected with SARS-CoV-2Assessing the therapeutic potential of agomelatine, ramelteon, and melatonin against SARS-CoV-2
animal testing
Melatonin drugs inhibit SARS-CoV-2 entry into the brain and virus-induced damage of cerebral small vessels